Drug Trial Radar · NCT07304518
Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
Last checked: Nov 19, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
456
Planned (sponsor's estimate)
Start
Jan 26, 2026
Primary completion
Sep 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- Sichuan Purity Pharmaceutical Technology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn about the efficacy and safety of PRT-064040 Nasal Spray versus placebo in the acute treatment of moderate or severe migraine.
Conditions
- Migraine
Interventions
PRT-064040 nasal sprayDrug
A single dose of PRT-064040 nasal spray
PlaceboDrug
A single dose of placebo matched to PRT-064040 nasal spray
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Freedom From Pain at 2 Hours Post-doseTime frame: 2 hours post-dose
- Percentage of Participants With Freedom From Most Bothersome Symptom (MBS) at 2 Hours Post-doseTime frame: 2 hours post-dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The First Medical Center of PLA General Hospital
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.